Effect of substituting glutamine with lysine on structural and biological properties of antimicrobial peptide

Hai Bui Thi Phuong1, Van Anh Tran1, Khoa Nguyen Ngoc1

  • 1Faculty of Pharmacy, Phenikaa University, Hanoi, 12116, Vietnam.

Amino Acids
|June 10, 2023
PubMed

Insights

A modified antimicrobial peptide, MP1-Q12K, shows enhanced antibacterial and antifungal activity. This peptide offers a promising new avenue for developing potent and selective antimicrobial therapies with improved safety profiles.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • The natural antimicrobial peptide Polybia-MP1 exhibits broad-spectrum antimicrobial and anticancer properties with high safety.
  • Previous modifications of Polybia-MP1 often led to increased hemolytic activity or reduced efficacy against Gram-negative bacteria and cancer cells.

Purpose of the Study:

  • To investigate the structure-activity relationships of Polybia-MP1 by creating a novel analog, MP1-Q12K.
  • To evaluate the antimicrobial, anticancer, and hemolytic activities of MP1-Q12K compared to the native peptide.

Main Methods:

  • Site-directed mutagenesis was employed to replace Glutamine at position 12 with Lysine, generating the MP1-Q12K analog.
  • Comparative analysis of antimicrobial (antibacterial, antifungal), anticancer, and hemolytic activities between Polybia-MP1 and MP1-Q12K.

Main Results:

  • MP1-Q12K demonstrated enhanced antibacterial and antifungal activity compared to Polybia-MP1.
  • Anticancer and hemolytic activities of MP1-Q12K were comparable to the native peptide.
  • MP1-Q12K exhibited reduced self-assembly compared to Polybia-MP1, correlating with enhanced antimicrobial properties.

Conclusions:

  • The substitution of Glutamine with Lysine at position 12 in Polybia-MP1 yields an analog with improved antimicrobial efficacy.
  • MP1-Q12K represents a promising candidate for developing potent and selective antimicrobial peptides with potential applications in infection and cancer treatment.